← Open Payments lookup

CATHERINE NGUYEN: Open Payments

NPI 1326316076 · WESTMINSTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,305 in 62 payments from 15 companies in 2025. Trend: 2023 $1,962 · 2024 $1,155 · 2025 $2,305

Food & beverage: $2,305
CompanyPaymentsAmount
Amgen Inc.11$501
Gilead Sciences, Inc.9$456
Lilly USA, LLC4$274
Bayer Healthcare Pharmaceuticals Inc.9$257
AstraZeneca Pharmaceuticals LP4$205
Viatris Specialty LLC4$189
ABBVIE INC.4$94
Boehringer Ingelheim Pharmaceuticals, Inc.3$66
Novo Nordisk Inc3$59
Exact Sciences Corporation3$58

Products named: Vemlidy, REPATHA, Kerendia, OTEZLA, JARDIANCE, YUPELRI, AIRSUPRA, ZEPBOUND.

Industry payments across CA — which companies pay providers there.